This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
American Geriatrics Society 2015 Beers Criteria Update Expert Panel: American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015; 63: 2227-2246.American Geriatrics Society 2015 Beers Criteria Update Expert Panel: American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsJ Am Geriatr Soc.2015632227224610.1111/jgs.13702Search in Google Scholar
Arranz FJ, Ros S. Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study. J Affect Disord. 1997; 46: 285-91.ArranzFJRosS.Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre studyJ Affect Disord.1997462859110.1016/S0165-0327(97)00092-XSearch in Google Scholar
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009; 373: 746-58.CiprianiAFurukawaTASalantiGGeddesJRHigginsJPChurchillRWatanabeNNakagawaAOmoriIMMcGuireHTansellaMBarbuiC.Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet20093737465810.1016/S0140-6736(09)60046-5Search in Google Scholar
Dew MA, Whyte EM, Lenze EJ, Houck PR, Mulsant BH, Pollock BG, Stack JA, Bensasi S, Reynolds CF. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry. 2007; 164: 892–899DewMAWhyteEMLenzeEJHouckPRMulsantBHPollockBGStackJABensasiSReynoldsCF.Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapyAm J Psychiatry200716489289910.1176/ajp.2007.164.6.89217541048Search in Google Scholar
Doan J, Zakrzewski-Jakubiak H, Roy J, Turgeon J, Tannenbaum C. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013; 47: 324-332DoanJZakrzewski-JakubiakHRoyJTurgeonJTannenbaumC.Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacyAnn Pharmacother20134732433210.1345/aph.1R62123482734Search in Google Scholar
Driscoll HC, Basinski J, Mulsant BH, Butters MA, Dew MA, Houck PR, Mazumdar S, Miller MD, Pollock BG, Stack JA, Schlernitzauer MA, Reynolds CF. Late-onset major depression: clinical and treatment-response variability. Int J Geriatr Psychiatry. 2005; 20: 661–667DriscollHCBasinskiJMulsantBHButtersMADewMAHouckPRMazumdarSMillerMDPollockBGStackJASchlernitzauerMAReynoldsCF.Late-onset major depression: clinical and treatment-response variabilityInt J Geriatr Psychiatry20052066166710.1002/gps.133416021664Search in Google Scholar
Driscoll HC, Karp JF, Dew MA, Reynolds CF. Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age. Drugs Aging. 2007; 24: 801–814DriscollHCKarpJFDewMAReynoldsCF.Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old ageDrugs Aging20072480181410.2165/00002512-200724100-0000217896830Search in Google Scholar
Gerson S, Belin TR, Kaufman A, Mintz J, Jarvik L. Pharmacological and psychological treatments for depressed older patients: a metaanalysis and overview of recent findings. Harv Rev Psychiatry. 1999; 7: 1-28.GersonSBelinTRKaufmanAMintzJJarvikL.Pharmacological and psychological treatments for depressed older patients: a metaanalysis and overview of recent findingsHarv Rev Psychiatry1999712810.3109/hrp.7.1.1Search in Google Scholar
Higgins JPT, Altman DG, Stearne JAC (editors). Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration (2011) www.cochrane-handbook.org.Accessed, March 2017.HigginsJPTAltmanDGStearneJACAssessing risk of bias in included studiesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)The Cochrane Collaboration2011www.cochrane-handbook.orgAccessedMarch2017Search in Google Scholar
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010; 107: 543-51.HoltSSchmiedlSThürmannPA.Potentially inappropriate medications in the elderly: the PRISCUS listDtsch Arztebl Int201010754351Search in Google Scholar
Jasiak NM, Bostwick JR. Risk of QT/QTc prolongation among newer non-SSRI antidepressants. Ann Pharmacother. 2014; 48: 1620-8.JasiakNMBostwickJR.Risk of QT/QTc prolongation among newer non-SSRI antidepressantsAnn Pharmacother2014481620810.1177/106002801455064525204465Search in Google Scholar
Khan A, Shad MU, Preskorn SH. Lack of sertraline efficacy probably due to an interaction with carbamazepine. J Clin Psychiatry. 2000; 61: 526-7.KhanAShadMUPreskornSH.Lack of sertraline efficacy probably due to an interaction with carbamazepineJ Clin Psychiatry200061526710.4088/JCP.v61n0712aSearch in Google Scholar
Mangerud WL, Bjerkeset O, Holmen TL, Lydersen S, Indredavik MS. Smoking, alcohol consumption, and drug use among adolescents with psychiatric disorders compared with a population based sample. J Adolesc. 2014; 37: 1189-1199.MangerudWLBjerkesetOHolmenTLLydersenSIndredavikMS.Smoking, alcohol consumption, and drug use among adolescents with psychiatric disorders compared with a population based sampleJ Adolesc.2014371189119910.1016/j.adolescence.2014.08.007Search in Google Scholar
Mann E, Haastert B, Böhmdorfer B, Frühwald T, Iglseder B, Roller-Wirnsberger R, Meyer G. Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study. Wien Klin Wochenschr. 2013; 125: 180-188.MannEHaastertBBöhmdorferBFrühwaldTIglsederBRoller-WirnsbergerRMeyerG.Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional studyWien Klin Wochenschr201312518018810.1007/s00508-013-0342-2Search in Google Scholar
McCusker J, Cole M, Keller E, Bellavance F, Berard A. Effectiveness of treatments of depression in older ambulatory patients. Arch Intern Med. 1998; 13; 158: 705-12.McCuskerJColeMKellerEBellavanceFBerardA.Effectiveness of treatments of depression in older ambulatory patientsArch Intern Med.1998131587051210.1001/archinte.158.7.705Search in Google Scholar
Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctôt KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord. 1997; 46: 191-217.MittmannNHerrmannNEinarsonTRBustoUELanctôtKLLiuBAShulmanKISilverILNarangoCAShearNH.The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysisJ Affect Disord19974619121710.1016/S0165-0327(97)00107-9Search in Google Scholar
Obach RS, Cox LM, Tremaine LM. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos. 2005; 33: 262-70.ObachRSCoxLMTremaineLM.Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro studyDrug Metab Dispos2005332627010.1124/dmd.104.00242815547048Search in Google Scholar
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015; 44: 213-8.O’MahonyDO’SullivanDByrneSO’ConnorMNRyanCGallagherP.STOPP/START criteria for potentially inappropriate prescribing in older people: version 2Age Ageing201544213810.1093/ageing/afu145433972625324330Search in Google Scholar
Practice guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition, APA. American Psychiatric Association (APA) treatment guidelines (2010). Available from: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdfPractice guideline for the Treatment of Patients with Major Depressive DisorderThirdAPAAmerican Psychiatric Association (APA) treatment guidelines2010Available fromhttps://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdfSearch in Google Scholar
Quality and Outwork framework 2012 (Accessed on 27 of January 2018): http://www.nhsemployers.org/Aboutus/Publications/Documents/QOF_2012-13.pdfQuality and Outwork framework2012(Accessed on 27 of January 2018)http://www.nhsemployers.org/Aboutus/Publications/Documents/QOF_2012-13.pdfSearch in Google Scholar
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 349: g7647.ShamseerLMoherDClarkeMGhersiDLiberatiAPetticrewMShekellePStewartLAPRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanationBMJ2015349g764710.1136/bmj.g764725555855Search in Google Scholar
Sinyor M, Schaffer A, Levitt A. The sequenced treatment alternatives to relieve depression (STAR∗D) trial: a review. Can J Psychiatry. 2010; 55: 126-35.SinyorMSchafferALevittA.The sequenced treatment alternatives to relieve depression (STAR∗D) trial: a reviewCan J Psychiatry2010551263510.1177/07067437100550030320370962Search in Google Scholar
Štuhec M. Duloxetine-induced life-threatening long QT syndrome. Wien Klin Wochenschr. 2013; 125: 165-6ŠtuhecM.Duloxetine-induced life-threatening long QT syndromeWien Klin Wochenschr2013125165610.1007/s00508-013-0330-623440523Search in Google Scholar
Tampi RR, Balderas M, Carter KV, Tampi DJ, Moca M, Knudsen A, May J. Citalopram, QTc Prolongation, and Torsades de Pointes. Psychosomatics. 2015; 56: 36-43.TampiRRBalderasMCarterKVTampiDJMocaMKnudsenAMayJ.Citalopram, QTc Prolongation, and Torsades de PointesPsychosomatics201556364310.1016/j.psym.2014.09.00225619672Search in Google Scholar
Thorlund K, Druyts E, Wu P, Balijepalli C, Keohane D, Mills E. Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis. J Am Geriatr Soc. 2015; 63: 1002-9.ThorlundKDruytsEWuPBalijepalliCKeohaneDMillsE.Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysisJ Am Geriatr Soc2015631002910.1111/jgs.1339525945410Search in Google Scholar
Wilkinson P, Izmeth Z. Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev. 2016; 9: CD006727.WilkinsonPIzmethZ.Continuation and maintenance treatments for depression in older peopleCochrane Database Syst Rev.20169CD00672710.1002/14651858.CD006727.pub223152240Search in Google Scholar
